Correlation of serum cholinesterase and acute physiology and chronic health evaluation Ⅱ score and multiple organ dysfunction syndrome score in patients with severe pneumonia

doi:10.3877/cma.j.issn.1674-6880.2016.03.004

Abstract

Abstract:

Objective

To observe the change of serum cholinesterase (S-ChE) levels in patients with severe pneumonia and its correlativity with acute physiology and chronic health evaluation Ⅱ(APACHE Ⅱ) score and multiple organ dysfunction syndrome (MODS) score.

Methods

A total of 86 patients with severe pneumonia were enrolled in this study as the severe pneumonia group, and divided into the survival group (46 cases) and death group (40 cases). And 100 patients with common pneumonia (common pneumonia group) and 124 people with health examination normal (control group) were served as control. The S-ChE levels were collected and APACHE Ⅱ score and MODS score were calculated after the patients were hospitalized in ICU within 24 hours. The Pearson correlation was used to analyze the association between S-ChE level and APACHE Ⅱ score as well as MODS score.

Results

The S-ChE levels in the severe pneumonia group, common pneumonia group and control group were (3 679 ± 1 433) U/L, (5 142 ± 1 884) U/L, (8 469 ± 1 377) U/L, respectively, and the S-ChE levels in the severe pneumonia group were much lower than those in the common pneumonia group and control group (all P<0.05). Meanwhile, the S-ChE levels in the death group [(2 748 ± 826) U/L vs. (4 489 ± 1 360) U/L, t=7.041, P<0.001] were much lower, whereas the APACHEⅡscores (26 ± 5 vs. 16 ± 5, t=8.540, P<0.001) and MODS scores (8.15 ± 2.49 vs. 4.35 ± 2.01, t=7.832, P<0.001) were higher than those in the survival group. The Pearson correlation showed that the S-ChE levels were negative related with APACHE Ⅱscore (r=-0.437, P<0.05) and MODS score (r=-0.337, P<0.05).

Conclusion

The S-ChE levels in patients with severe pneumonia decrease remarkedly, which can reflect the severity of severe pneumonia and have negative correlation with APACHE Ⅱscore or MODS score.

Key words: Cholinesterase, Pneumonia, APACHE, Multiple organ dysfunction syndrome

Xin Mo, Yanbing Liang, Zhibin Chen, Zhenyu Li, Bingyu Yang, Zhongfu Ma. Correlation of serum cholinesterase and acute physiology and chronic health evaluation Ⅱ score and multiple organ dysfunction syndrome score in patients with severe pneumonia[J]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2016, 09(03): 159-162.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhwzzyxzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-6880.2016.03.004

https://zhwzzyxzz.cma-cmc.com.cn/EN/Y2016/V09/I03/159

Figures/Tables 2

References 21

[1]	Mandell LA, Wunderink RG, Anzueto A, et al.Infectious Diseases Society of American/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adult[J].Clin Infect Dis, 2007 (44 Suppl 2): S27-S72.
[2]	Richard G, Levy H, Laterre PF, et al.CURB-65, PSI, and APACHE II to assess mortality risk in patients with severe sepsis and community acquired pneumonia in PROWESS[J].J Intensive Care Med, 2011, 26 (1): 34-40.
[3]	田金飞，汤彦，向小卫，等.动态APACHE Ⅲ联合MODS评分在ICU临床研究中的应用[J].职业与健康，2011，27（4）：370-372.
[4]	中华医学会呼吸病学分会.社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志，2006，29（10）：651-655.
[5]	王超，苏强，张淑文，等.多器官功能障碍综合征病情严重度评分系统[J].中国医学科学院学报，2007，29（4）：497-500.
[6]	张细江.老年重症社区获得性肺炎患者血清胆碱酯酶的变化及意义[J].中国急救医学，2009，29（12）：1081-1083.
[7]	Kanai S, Honda T, Uehara T, et al.Liver function tests In Patients with bacteremia[J].J Clin Lab Anal, 2008,22 (1): 66-69.
[8]	al-Kassab AS, Vijayakumar E.Profile of serum choline-sterase in systemic sepsis syndrome(septic shock) in intensive care unit patients[J].Eur J Clin Chem Clin Biochem, 1995, 33 (1): 11-14.
[9]	Wolkmer P, Lopes ST, Franciscato C, et al.Trypanosoma evansi: cholinesterase activity in acutely infected Wistar rats[J].Exp Parasitol, 2010, 125 (3): 251-255.
[10]	杨青茹，吴焱旻，张敬浩，等.老年重症肺炎血清胆碱酯酶、前白蛋白与预后[J].临床肺科杂志，2012，17（12）：2194-2196.
[11]	刘金涛，王绍红，陈若冰.血清胆碱酯酶在危重症感染患者中的变化对其预后的探索[J].中国医学创新，2013，10（26）：126-127.
[12]	刘进，王磊.胆碱酯酶对判断全身炎症反应综合征患者预后的价值[J].临床荟萃，2012，27（1）：48-49.
[13]	张细江，何宗广.感染性休克患者血清胆碱酯酶的变化及临床意义[J].中国急救复苏与灾害医学杂志，2013，8（1）：26-29.
[14]	卑源琪，陆俊国，陶勇，等.血清胆碱酯酶水平对脓毒症患者病情判断意义[J].交通医学，2013，27（6）：658-659.
[15]	朱睿瑶，张迪，冯丽芝，等.血乳酸、胆碱脂酶与APACHEⅡ评分在评估危重症患者病情预后中的研究[J].医学研究杂志，2014，43（3）：65-67.
[16]	Hsieh BC, Hsiao HY, Cheng TJ, et al. Assays for serum cholinesterase activity by capillary electrophoresis and an amperometric flow injection choline biosensor[J].Anal Chim Acta, 2008, 623 (2): 157-162.
[17]	陈文彬，潘祥林.诊断学[M].第8版.北京：人民卫生出版社，2013：398.
[18]	黄帆，杨静，仲飞，等.大面积脑梗死患者早期血清胆碱酯酶活性检测的临床意义[J].热带医学杂志，2008，8（10）：1046-1048.
[19]	郑建琼，黄德斌.老年脓毒症患者血清清蛋白、D-二聚体及胆碱酯酶检测意义[J].中国老年学杂志，2014，34（13）：3522-3523.
[20]	李艳华，张国荣，任连峰.多器官功能障碍障碍综合征的血清白蛋白及胆碱酯酶肌钙蛋白T水平的意义和预后的关系[J].河北医学，2013，19（4）：490-492.
[21]	施新萍，楼利剑，娄域峰.肺部疾病引发全身炎症反应综合征的老年患者死亡因素分析[J/CD].中华危重症医学杂志：电子版，2011，4（1）：26-30.

组别	例数	S-ChE（U/L）
对照组	124	8 469 ± 1 377
普通肺炎组	100	5 142 ± 1 884^a
重症肺炎组	86	3 679 ± 1 434^ab
F值	?	261.069
P值	?	<0.001

组别	例数	S-ChE（U/L）
对照组	124	8 469 ± 1 377
普通肺炎组	100	5 142 ± 1 884^a
重症肺炎组	86	3 679 ± 1 434^ab
F值	?	261.069
P值	?	<0.001

组别	例数	检测指标
组别	例数	年龄（岁）	性别（男/女）	S-ChE（U/L）	APACHE Ⅱ评分（分）	MODS评分（分）
存活组	46	62 ± 19	22/24	4 489 ± 1 360	16 ± 5	4.4 ± 2.0
死亡组	40	66 ± 17	26/14	2 748 ± 826	26 ± 5	8.2 ± 2.5
t/χ²值	?	1.047	2.559	7.041	8.540	7.832
P值	?	0.298	0.110	<0.001	<0.001	<0.001

组别	例数	检测指标
组别	例数	年龄（岁）	性别（男/女）	S-ChE（U/L）	APACHE Ⅱ评分（分）	MODS评分（分）
存活组	46	62 ± 19	22/24	4 489 ± 1 360	16 ± 5	4.4 ± 2.0
死亡组	40	66 ± 17	26/14	2 748 ± 826	26 ± 5	8.2 ± 2.5
t/χ²值	?	1.047	2.559	7.041	8.540	7.832
P值	?	0.298	0.110	<0.001	<0.001	<0.001

Please choose a citation manager

Content to export